JPRN-UMIN000002341
Completed
N/A
Investigation of biomarkers for predicting effectiveness of treatments for Crohn's disease - Biomarkers of Crohn's disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Crohn'
- Sponsor
- Osaka University Graduate School of Medicine
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with Crohn's disease who are not applicable to Infliximab treatment and who do not give written informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Investigation of biomarkers for predicting effectiveness of treatments for inflammatory bowel diseasesinflammatory bowel diseasesJPRN-UMIN000005032Saitama medical Center, Saitama medical University200
Completed
N/A
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
Completed
N/A
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
Recruiting
N/A
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50
Completed
N/A
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100